It is critical to find alternatives to native vein or artery for use in vascular surgery, as adequate tissue for a bypass conduit is often unavailable. Animal studies have shown that a tubing template implanted into the peritoneal cavity becomes covered with tissue, and this newly formed tissue tube can be used as a vascular graft. However, due to the nature of animal models used, it is difficult to investigate the development of this tissue at the cellular/molecular level. To understand this mechanism, we have developed a mouse model where the newly formed vessels were transplanted into the abdominal aortae of the same mice in which they were grown. These grafts remained patent for at least 4 months, and in situ they developed the architecture of normal blood vessels. Comprehensive genotypic and phenotypic analysis revealed that the mouse tissue capsule cells and peritoneal cells have the characteristics of stem/progenitor cells including the expression of transcription factors that are specific to stem cells, the presence of side population cells, as well as Lin-/Sca-1+/c-kit+ cells. Functional analyses revealed that these peritoneal cells are biologically active, as shown by their ability to: stimulate re-perfusion/neovascularization of ischemic hind limb; repopulate the hematopoietic system of lethally irradiated mice; and graft into various organ of recipient mice. We propose to: 1) Determine the contribution of peritoneal-derived stem cells to generation of tissue capsule; 2) D Determine the role of peritoneal-derived stem cells in the remodeling of capsule graft;
Aim 3) Determine functionality of peritoneal stem cell sub-population. Accomplishing these Specific Aims will elucidate the mechanisms by which peritoneal cells contribute to the development of bioengineered tissues and may lead to the development of novel strategies for tissue bioengineering and reperfusion of a variety of ischemic tissues.

Public Health Relevance

Vascular bypass grafting is the mainstay of revascularization for ischemic heart disease and peripheral vascular disease, and in the US alone 1.4 million arterial bypass operations are performed annually. However, 30% of patients who require arterial bypass procedures have no suitable autologous arteries or veins for use. In animal models, it has been shown that tubular structures can be grown in the peritoneal cavity, and that they can function as autologous graft while undergoing extensive remodeling to resemble native vessels. The mechanisms for this process of tissue generation, and subsequent remodeling have been have been poorly understood due to the animals species used thus far; however by using our mouse model in the proposed studies we shall elucidate these mechanisms at a cell and molecular level, which will in turn have significant implications for our ability to treat ischemic vascular diseases. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL090653-01A1
Application #
7524564
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Lundberg, Martha
Project Start
2008-08-01
Project End
2012-06-30
Budget Start
2008-08-01
Budget End
2009-06-30
Support Year
1
Fiscal Year
2008
Total Cost
$406,250
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Song, Lei; Wang, Lai; Li, Fuqiang et al. (2017) Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation. J Am Coll Cardiol 70:1601-1615
Li, Fuqiang; Yang, Mingjie; Wang, Lai et al. (2012) Autofluorescence contributes to false-positive intracellular Foxp3 staining in macrophages: a lesson learned from flow cytometry. J Immunol Methods 386:101-7
Wang, Lai; Wang, Wei; Shah, Prediman K et al. (2012) Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice. Cardiovasc Pathol 21:398-413
Li, Fuqiang; Tian, Fang; Wang, Lai et al. (2010) Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages. FASEB J 24:810-22
Song, Lei; Wang, Lai; Shah, Prediman K et al. (2010) Bioengineered vascular graft grown in the mouse peritoneal cavity. J Vasc Surg 52:994-1002, 1002.e1-2
Meisel, Simcha R; Ouyang, Yi; Fishbein, Michael C et al. (2010) Prolonged hypercholesterolemia-induced tissue factor expression in rabbit vein grafts: a potential mechanism for graft failure. Coron Artery Dis 21:97-103
Dimayuga, Paul C; Cesena, Fernando H Y; Chyu, Kuang-Yuh et al. (2009) Natural antibodies and complement modulate intimal thickening after arterial injury. Am J Physiol Regul Integr Comp Physiol 297:R1593-600